Across the whole pharma sector, there are four or five stocks big one out there which are going to gain market share. So, CDMO is one space within pharma which should do well as we go along. But pharma as a whole space per se has been doing okay and we continue to believe that incrementally also pharma should continue to do well in the coming year also.
Sebi mandates simplified compliance for listed entities with integrated filing framework
Sebi introduces a new compliance framework for listed entities, integrating governance and financial disclosures into a single filing system starting from December 31, 2024. The
January 1, 2025